/Companies

Deep Tech Startups

8,457 companies tagged Deep Tech, with their investors and founders.

OpenStar Technologies

OpenStar develops compact fusion energy technology using a levitated dipole approach and high-temperature superconducting systems, working toward commercial fusion. The company originated from the Robinson Research Institute in New Zealand.

5 investors

Optios

Optios operates an AI platform that collects neurophysiological data via unobtrusive sensors and analyzes it in real time to deliver brain-activity insights, neuro-cognitive metrics, and interventions aimed at optimizing human performance. Its capabilities include training and coaching, neurofeedback, neuromodulation, human-machine team optimization, and AI agent optimization, built on a foundation model for the brain.

5 investors

OptQC Corp.

OptQC develops optical quantum computers aimed at practical societal implementation, addressing energy efficiency and computational capacity limits through a scalable photonic approach to quantum computing.

5 investors

Oratomic

Oratomic builds fault-tolerant quantum computers using ultra-efficient error correction with light and atoms. The company aims to create utility-scale quantum systems for applications in artificial intelligence and scientific discovery.

5 investors

Ori Biotech

Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.

5 investors

Osium AI

Osium AI develops an AI-powered platform that helps industry leaders accelerate materials innovation and discovery by optimizing experimentation and managing research data. The platform serves companies in the materials science, chemicals, and related industries seeking to improve material performance and sustainability.

5 investors

Osmo

Osmo develops artificial intelligence and computational tools for fragrance creation and ingredient discovery. The company serves perfumers, fragrance houses, and consumer brands by providing an Olfactory Intelligence platform that digitizes and predicts scent from molecular structure.

5 investors

OTI Lumionics Inc

OTI Lumionics develops advanced materials for electronics, focused on key enabling materials for OLED displays used in next-generation consumer electronics and automotive, including electrode materials and self-assembly patterning technology. It uses a computational Materials Discovery Platform combining quantum simulations and machine learning with in-house pilot production testing, and works with Tier 1 chemical partners for scale-up.

5 investors

Pantheon Design

Pantheon Design manufactures 3D printers designed for hardware engineers and product developers. The company serves teams building physical products including automotive parts, medical devices, and custom mechatronics systems.

5 investors

Parallelfluidics

Parallel Fluidics builds microfluidic products for life science teams, helping them move from concept to working device for applications like drug discovery and disease diagnostics. The company operates in the microfluidics and life science tooling space.

5 investors

Parallelz

Parallelz is building a computing architecture and platform that converts existing native mobile apps into native-web apps without code modifications or SDKs, allowing them to run in a browser without installs or app stores. It targets mobile app developers, including in mobile gaming, in the app distribution and discovery space.

5 investors

Patronus AI

Patronus AI is a frontier research lab building Digital World Models that predict and simulate agent actions in digital workflows to generate large-scale training simulations for frontier AI models. Its simulations span domains including research science, software development, customer service, product applications, and finance, aimed at advancing continual learning toward human-aligned AGI.

5 investors

Peptone

Peptone develops a product engine to design small-molecule drug candidates targeting intrinsically disordered proteins, which have been difficult to address with conventional drug discovery approaches.

5 investors

Perigee

Perigee is involved in space launch and propulsion technologies. This investors/IR page provides shareholder notices and meeting announcements but gives little concrete detail about the company's products or operations.

5 investors

Perseus Proteomics

Perseus Proteomics develops and supplies research antibodies targeting nuclear receptors and transcription factors, along with ELISA kits and diagnostic assays, serving life sciences researchers and pharmaceutical development. The company provides approximately 100 antibody products including anti-ERβ antibodies established as the gold standard for ERβ research, as well as specialized antibodies for drug-antibody conjugates and radioimmunoterapy applications.

5 investors

Phantasma Labs

Phantasma Labs builds industrial-grade AI software using Reinforcement Learning to create models without large datasets, applying simulations to areas such as production planning for factories and navigation for autonomous vehicles. It targets manufacturers and enterprises of any size, aiming to make AI adoption accessible regardless of digital maturity.

5 investors

Phantom Space

Phantom Space Corporation builds small satellite launch vehicles and satellites, along with its Phantom Cloud data-center constellations, to provide launch and in-space delivery services. The U.S.-controlled company targets customers seeking access to space transportation, satellite manufacturing, and space data.

5 investors

Phasecraft

Phasecraft develops quantum computing systems and software by combining quantum information theory, materials science, and engineering to advance practical quantum advantage. The company serves organizations seeking to apply quantum computing to real-world problems.

5 investors

Phenomic AI

Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.

5 investors

phlair

Phlair is a team of engineers and scientists developing electrochemical and process-engineering technology, with work focused on carbon capture/direct air capture based on its absorption, electrochemistry, and stack assembly roles.

5 investors

Photonic

Photonic is developing a commercial-scale, fault-tolerant quantum computer based on silicon T centres, using a distributed architecture designed for manufacturability and scaling. The company targets quantum computing applications such as drug discovery, financial modelling, cryptography, logistics, materials science, and climate simulation.

5 investors

Planetary

Planetary Technologies develops ocean-based carbon removal technology to address climate change. The company operates projects focused on capturing and storing carbon through marine processes.

5 investors

Point Nine

Anthropic is an AI company that develops large language models, including its Claude models used by developers. The company reported a revenue run-rate growing from $1B to $9B during 2025 and later crossing $30B–$40B in annualized revenue.

5 investors

Point2 Technology

Point2 Technology develops interconnect chips and cables that use RF transmission over plastic waveguide ("e-Tube") to move data between servers in AI data centers, targeting 400G/800G and terabit-scale links as an alternative to copper and optical connections. It builds low-power interconnect SoCs and retimers aimed at reducing latency, power, and total cost of ownership for data center infrastructure.

5 investors

Other sectors & tags